PRESENTATIONS
PIPELINE PRESENTATIONS
A Target of Opportunity – Shaping the Future of FAPI
Sponsored by SOFIE
Satellite Symposium, 2025 Annual SNMMI Meeting – New Orleans, LA
June 22, 2025
Current State of FAP Targeting Radioligands in Oncology
Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
SOFIE Educational Webinar Series
June 18, 2025
Imaging Cancer through the Stroma – FAPI PET/CT, a Novel Tracer in Oncology
Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
2024 ATAWM and CCSNMMI Michigan Road Show – Grand Rapids, Michigan
November 9, 2024
FAPI-PET imaging & theranostics: A new era in targeting cancer and fibrotic diseases
Presented by: John Babish – Ratio Therapeutics, Sherly Mosessian, PhD – SOFIE Chief Scientific Officer, Jeremie Calais – Dept of Molecular and Medical Pharmacology, Ken Hermann – Nuclear Medicine Physician
Endpoints Webinars – November 7, 2024
[68Ga]FAPI-46 Phase 2 clinical development updates
Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
2024 Annual SNMMI Meeting – Toronto, Canada
June 9, 2024
![[68Ga]FAPI-46 Phase 2 clinical development updates](https://sofie.com/wp-content/uploads/2024/06/FAPI_Presentation2.jpg)
Current State of FAP Targeting Radioligands
Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
May 30, 2024
Advancements in Diagnostics
Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
7th Theranostics World Congress – Santiago, Chile
March 23, 2024
Fibroblast Activation Protein (FAP) – a target for Imaging and Therapy
Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
Targeted Radiopharmaceuticals Summit US (TRP) – Boston, Massachusetts
July 25, 2023
FAP Ligands for Imaging and Therapy
Sponsored by SOFIE
Satellite Symposium, 2023 Annual SNMMI Meeting – Chicago, IL
June 25, 2023
SOFIE FAPI diagnostic-clinical development updates
Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
2023 Annual SNMMI Meeting – Chicago, Illinois
June 25, 2023
Webinar: Current State of FAP Ligands for Diagnostic Use in Oncology
Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
June 14, 2023
FAPI Theragnostics
Presented by: Prof. Dr. Frederik L. Giesel, MD, MBA; Chair of Nuclear Medicine, Department of Nuclear Medicine; University Hospital Düsseldorf, Germany
World Theragnostics Day – Focus on FAPI
March 31, 2023
Fibroblast Activation Protein (FAP) Inhibitors as Biomarkers in Oncology, Fibrotic Disease, and Cardiovascular Disease
Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
Informa Connect: Radiopharmaceuticals and Imaging Digital Conference
March 14, 2023
FAPI Clinical Development Updates
Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
ICPO Theranostics FAP Summit (virtual)
November 5, 2022
Current Status of Clinical Trials on FAP Targeted Radiopharmaceuticals
Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
Gordon Research Conference-Radionuclide Theranostics for the Management of Cancer – Newry, Maine
July 19, 2022
FAP Ligands for Imaging and Therapy
SOFIE/Clovis Oncology/POINT Biopharma
Satellite Symposium, 2022 Annual SNMMI Meeting – Vancouver Canada
June 12, 2022
FAP-Ligand PET Update ≠ Cancer
Presented by: Professor Jeremie Calais, MD, MSc, Professor, University of California, Los Angeles
2022 Annual SNMMI Meeting – Vancouver, Canada
June 12, 2022
SOFIE FAPI Clinical Development Update
Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
2022 Annual SNMMI Meeting – Vancouver, Canada
June 12, 2022
Webinar: Fibroblast Activation Protein (FAP) – A promising target for radiopharmaceuticals
Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
June 8, 2022
2019 SNMMI Image of the Year
Presented by: Professor Frederik L. Giesel, MD, MBA, University Hospital Düsseldorf, Germany
2019 Annual SNMMI Meeting – Anaheim, CA
June 25, 2019